IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTINA MATHEW

NPI
1396323663
CMS profile
11551948
Location
LARGO, FL

General Payments · PY2023–2024

$1,722.13

  • Reported across 82 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,135.60

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: FL All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,130.43 52
Education $5.17 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $256.24 15
Supernus Pharmaceuticals, Inc. $245.34 9
ITI, Inc. $157.83 8
ABBVIE INC. $107.21 5
Janssen Pharmaceuticals, Inc $95.91 3
Otsuka America Pharmaceutical, Inc. $70.72 3
Neurocrine BioSciences, Inc. $46.55 2
Noven Therapeutics, LLC $35.49 2
Almatica Pharma Inc. $27.59 1
Lundbeck LLC $23.12 1
Alkermes, Inc. $21.49 1
Indivior Inc. $18.50 1
IDORSIA PHARMACEUTICALS US INC $15.78 1
Axsome Therapeutics, Inc. $13.83 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $586.53 29
PY2024 $1,135.60 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.92 01/05/2024 Food and Beverage Undisputed 01/23/2026 1104982625 CMS
ABBVIE INC. $20.94 02/21/2024 Food and Beverage Undisputed 01/23/2026 1104982627 CMS
ABBVIE INC. $23.14 04/03/2024 Food and Beverage Undisputed 01/23/2026 1104982629 CMS
ABBVIE INC. $23.40 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104982631 CMS
ABBVIE INC. $19.81 07/11/2024 Food and Beverage Undisputed 01/23/2026 1104982633 CMS
Alkermes, Inc. $21.49 02/20/2024 Food and Beverage Undisputed 01/23/2026 1120549283 CMS
Almatica Pharma LLC $27.59 12/12/2024 Food and Beverage Undisputed 01/23/2026 1137571244 CMS
Axsome Therapeutics, Inc. $13.83 04/19/2024 Food and Beverage Undisputed 01/23/2026 1148271807 CMS
IDORSIA PHARMACEUTICALS US INC $15.78 03/05/2024 Food and Beverage Undisputed 01/23/2026 1146794726 CMS
Indivior Inc. $18.50 01/26/2024 Food and Beverage Undisputed 01/23/2026 1144533107 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.53 01/11/2024 Food and Beverage Undisputed 01/23/2026 1143272522 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.50 01/18/2024 Food and Beverage Undisputed 01/23/2026 1143272526 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.92 02/08/2024 Food and Beverage Undisputed 01/23/2026 1143272529 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.77 02/16/2024 Food and Beverage Undisputed 01/23/2026 1143272533 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.20 03/07/2024 Food and Beverage Undisputed 01/23/2026 1143272537 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.07 04/04/2024 Food and Beverage Undisputed 01/23/2026 1143272541 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.99 04/26/2024 Food and Beverage Undisputed 01/23/2026 1143272544 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.85 05/01/2024 Food and Beverage Undisputed 01/23/2026 1143272548 CMS
Janssen Pharmaceuticals, Inc $22.68 03/07/2024 Food and Beverage Undisputed 01/23/2026 1077965684 CMS
Janssen Pharmaceuticals, Inc $29.50 04/10/2024 Food and Beverage Undisputed 01/23/2026 1077965700 CMS
Janssen Pharmaceuticals, Inc $43.73 04/24/2024 Food and Beverage Undisputed 01/23/2026 1077965542 CMS
Lundbeck LLC $23.12 02/16/2024 Food and Beverage Undisputed 01/23/2026 1145943768 CMS
Neurocrine Biosciences, Inc. $30.41 01/17/2024 Food and Beverage Undisputed 01/23/2026 1150825266 CMS
Neurocrine Biosciences, Inc. $16.14 12/10/2024 Food and Beverage Undisputed 01/23/2026 1150871778 CMS
Noven Therapeutics, LLC $17.22 01/31/2024 Food and Beverage Undisputed 01/23/2026 1084819378 CMS
Noven Therapeutics, LLC $18.27 05/29/2024 Food and Beverage Undisputed 01/23/2026 1084819380 CMS
Otsuka America Pharmaceutical, Inc. $28.73 02/05/2024 Food and Beverage Undisputed 01/23/2026 1118937480 CMS
Otsuka America Pharmaceutical, Inc. $16.82 02/07/2024 Food and Beverage Undisputed 01/23/2026 1118937482 CMS
Otsuka America Pharmaceutical, Inc. $25.17 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118937484 CMS
Supernus Pharmaceuticals, Inc. $22.26 01/02/2024 Food and Beverage Undisputed 01/23/2026 1147883192 CMS
Supernus Pharmaceuticals, Inc. $5.17 01/09/2024 Education Undisputed 01/23/2026 1147883182 CMS
Supernus Pharmaceuticals, Inc. $102.19 01/09/2024 Food and Beverage Undisputed 01/23/2026 1147883196 CMS
Supernus Pharmaceuticals, Inc. $70.74 01/30/2024 Food and Beverage Undisputed 01/23/2026 1147883194 CMS
Supernus Pharmaceuticals, Inc. $3.86 02/07/2024 Food and Beverage Undisputed 01/23/2026 1147883180 CMS
Supernus Pharmaceuticals, Inc. $14.92 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147883188 CMS
Supernus Pharmaceuticals, Inc. $5.47 04/03/2024 Food and Beverage Undisputed 01/23/2026 1147883186 CMS
Supernus Pharmaceuticals, Inc. $5.33 12/24/2024 Food and Beverage Undisputed 01/23/2026 1147883184 CMS
Supernus Pharmaceuticals, Inc. $15.40 12/24/2024 Food and Beverage Undisputed 01/23/2026 1147883190 CMS
Teva Pharmaceuticals USA, Inc. $16.90 01/09/2024 Food and Beverage Undisputed 01/23/2026 1151749230 CMS
Teva Pharmaceuticals USA, Inc. $14.70 01/24/2024 Food and Beverage Undisputed 01/23/2026 1151749344 CMS
Teva Pharmaceuticals USA, Inc. $25.25 02/06/2024 Food and Beverage Undisputed 01/23/2026 1151749356 CMS
Teva Pharmaceuticals USA, Inc. $16.42 03/21/2024 Food and Beverage Undisputed 01/23/2026 1151749366 CMS
Teva Pharmaceuticals USA, Inc. $6.10 04/02/2024 Food and Beverage Undisputed 01/23/2026 1151749376 CMS
Teva Pharmaceuticals USA, Inc. $20.59 04/18/2024 Food and Beverage Undisputed 01/23/2026 1151749378 CMS
Teva Pharmaceuticals USA, Inc. $9.52 06/11/2024 Food and Beverage Undisputed 01/23/2026 1151749410 CMS
Teva Pharmaceuticals USA, Inc. $16.75 06/11/2024 Food and Beverage Undisputed 01/23/2026 1151749412 CMS
Teva Pharmaceuticals USA, Inc. $22.10 06/18/2024 Food and Beverage Undisputed 01/23/2026 1151749414 CMS
Teva Pharmaceuticals USA, Inc. $23.12 07/16/2024 Food and Beverage Undisputed 01/23/2026 1151749424 CMS
Teva Pharmaceuticals USA, Inc. $4.48 08/20/2024 Food and Beverage Undisputed 01/23/2026 1151749430 CMS
Teva Pharmaceuticals USA, Inc. $23.38 08/20/2024 Food and Beverage Undisputed 01/23/2026 1151749432 CMS
Teva Pharmaceuticals USA, Inc. $14.80 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151749446 CMS
Teva Pharmaceuticals USA, Inc. $22.20 09/24/2024 Food and Beverage Undisputed 01/23/2026 1151749448 CMS
Teva Pharmaceuticals USA, Inc. $19.93 12/04/2024 Food and Beverage Undisputed 01/23/2026 1151749472 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.